Prognostic characteristics of cardiopulmonary exercise testing in caucasian and African American patients with heart failure

Ross Arena, Jonathan Myers, Joshua Abella, Mary Ann Peberdy, Daniel Bensimhon, Paul Chase, Marco Guazzi

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Peak oxygen consumption (VO2) and ventilatory efficiency (minute ventilation/carbon dioxide output [VE/VCO2] slope) are prognostically important in heart failure (HF). The purpose of the present study was to compare the prognostic characteristics of these variables between Caucasian and African American patients. A total of 662 HF patients (455 Caucasian/207 African American) underwent cardiopulmonary exercise testing and were tracked for major cardiac events. The VE/VCO2 slope was the strongest prognostic marker (chi-square ≥18.9, P2 was a significant univariate predictor in both Caucasian (chi-square 42.0, P2 in the African American subgroup was due to its lack of prognostic significance in female patients. While the VE/VCO2 slope was the most robust prognostic marker in both Caucasian and African American patients, the predictive ability of peak VO2 seems to be influenced by race and sex.

Original languageEnglish
Pages (from-to)310-315
Number of pages6
JournalCongestive Heart Failure
Volume14
Issue number6
DOIs
Publication statusPublished - Nov 2008

Fingerprint

African Americans
Heart Failure
Exercise
Carbon Dioxide
Oxygen Consumption
Ventilation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Emergency Medicine
  • Emergency

Cite this

Prognostic characteristics of cardiopulmonary exercise testing in caucasian and African American patients with heart failure. / Arena, Ross; Myers, Jonathan; Abella, Joshua; Peberdy, Mary Ann; Bensimhon, Daniel; Chase, Paul; Guazzi, Marco.

In: Congestive Heart Failure, Vol. 14, No. 6, 11.2008, p. 310-315.

Research output: Contribution to journalArticle

Arena, Ross ; Myers, Jonathan ; Abella, Joshua ; Peberdy, Mary Ann ; Bensimhon, Daniel ; Chase, Paul ; Guazzi, Marco. / Prognostic characteristics of cardiopulmonary exercise testing in caucasian and African American patients with heart failure. In: Congestive Heart Failure. 2008 ; Vol. 14, No. 6. pp. 310-315.
@article{6e50d9b23e4e445591b863274f50aac7,
title = "Prognostic characteristics of cardiopulmonary exercise testing in caucasian and African American patients with heart failure",
abstract = "Peak oxygen consumption (VO2) and ventilatory efficiency (minute ventilation/carbon dioxide output [VE/VCO2] slope) are prognostically important in heart failure (HF). The purpose of the present study was to compare the prognostic characteristics of these variables between Caucasian and African American patients. A total of 662 HF patients (455 Caucasian/207 African American) underwent cardiopulmonary exercise testing and were tracked for major cardiac events. The VE/VCO2 slope was the strongest prognostic marker (chi-square ≥18.9, P2 was a significant univariate predictor in both Caucasian (chi-square 42.0, P2 in the African American subgroup was due to its lack of prognostic significance in female patients. While the VE/VCO2 slope was the most robust prognostic marker in both Caucasian and African American patients, the predictive ability of peak VO2 seems to be influenced by race and sex.",
author = "Ross Arena and Jonathan Myers and Joshua Abella and Peberdy, {Mary Ann} and Daniel Bensimhon and Paul Chase and Marco Guazzi",
year = "2008",
month = "11",
doi = "10.1111/j.1751-7133.2008.00024.x",
language = "English",
volume = "14",
pages = "310--315",
journal = "Prevention and Management of Congestive Heart Failure",
issn = "1527-5299",
publisher = "Le Jacq Communications, Inc.",
number = "6",

}

TY - JOUR

T1 - Prognostic characteristics of cardiopulmonary exercise testing in caucasian and African American patients with heart failure

AU - Arena, Ross

AU - Myers, Jonathan

AU - Abella, Joshua

AU - Peberdy, Mary Ann

AU - Bensimhon, Daniel

AU - Chase, Paul

AU - Guazzi, Marco

PY - 2008/11

Y1 - 2008/11

N2 - Peak oxygen consumption (VO2) and ventilatory efficiency (minute ventilation/carbon dioxide output [VE/VCO2] slope) are prognostically important in heart failure (HF). The purpose of the present study was to compare the prognostic characteristics of these variables between Caucasian and African American patients. A total of 662 HF patients (455 Caucasian/207 African American) underwent cardiopulmonary exercise testing and were tracked for major cardiac events. The VE/VCO2 slope was the strongest prognostic marker (chi-square ≥18.9, P2 was a significant univariate predictor in both Caucasian (chi-square 42.0, P2 in the African American subgroup was due to its lack of prognostic significance in female patients. While the VE/VCO2 slope was the most robust prognostic marker in both Caucasian and African American patients, the predictive ability of peak VO2 seems to be influenced by race and sex.

AB - Peak oxygen consumption (VO2) and ventilatory efficiency (minute ventilation/carbon dioxide output [VE/VCO2] slope) are prognostically important in heart failure (HF). The purpose of the present study was to compare the prognostic characteristics of these variables between Caucasian and African American patients. A total of 662 HF patients (455 Caucasian/207 African American) underwent cardiopulmonary exercise testing and were tracked for major cardiac events. The VE/VCO2 slope was the strongest prognostic marker (chi-square ≥18.9, P2 was a significant univariate predictor in both Caucasian (chi-square 42.0, P2 in the African American subgroup was due to its lack of prognostic significance in female patients. While the VE/VCO2 slope was the most robust prognostic marker in both Caucasian and African American patients, the predictive ability of peak VO2 seems to be influenced by race and sex.

UR - http://www.scopus.com/inward/record.url?scp=57849090022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57849090022&partnerID=8YFLogxK

U2 - 10.1111/j.1751-7133.2008.00024.x

DO - 10.1111/j.1751-7133.2008.00024.x

M3 - Article

VL - 14

SP - 310

EP - 315

JO - Prevention and Management of Congestive Heart Failure

JF - Prevention and Management of Congestive Heart Failure

SN - 1527-5299

IS - 6

ER -